Close Menu

NEW YORK — Ardigen and The BioCollective said on Wednesday that they have partnered on the development of metagenomic biomarkers for Parkinson's disease.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.